LFCR (Lifecore Biomedical, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings
Lifecore Biomedical, Inc. Common Stock (LFCR) is a publicly traded Healthcare sector company. As of May 21, 2026, LFCR trades at $4.57 with a market cap of $164.29M and a P/E ratio of -3.53. LFCR moved +4.34% today. Year to date, LFCR is -41.41%; over the trailing twelve months it is -31.07%. Its 52-week range spans $3.63 to $8.98. Analyst consensus is strong buy with an average price target of $6.67. Rallies surfaces LFCR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns LFCR stock?
Hedge funds tracked by Rallies that own LFCR include Exoduspoint Capital. The latest tracked quarter is Sep 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Lifecore Biomedical, Inc. Common Stock.
LFCR Key Metrics
Key financial metrics for LFCR
Metric
Value
Price
$4.57
Market Cap
$164.29M
P/E Ratio
-3.53
EPS
$-1.27
Dividend Yield
0.00%
52-Week High
$8.98
52-Week Low
$3.63
Volume
0
Avg Volume
0
Revenue (TTM)
$128.87M
Net Income
$-38.72M
Gross Margin
31.27%
Top Hedge Funds Holding LFCR
Exoduspoint Capital holds 15.93K shares of LFCR, changed -61.64% as of Sep 30, 2025.
Hedge funds tracked by Rallies that own LFCR include Exoduspoint Capital. The latest tracked quarter is Sep 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Lifecore Biomedical, Inc. Common Stock.
Does Rallies show 13F holders for LFCR?
Yes. Rallies tracks hedge fund and 13F ownership data for LFCR, including fund names, share counts, latest tracked quarter, and position changes when available.
Is LFCR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for LFCR. It does not provide personalized investment advice.
